BridgeMD
New treatment option for Acute Kidney Injury
Official title Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial
ClinicalTrials.gov ID: NCT07670520
What this study is testing
- What it's testing
- The purpose of this study is to determine the effect of a multidisciplinary intervention at care transitions for acute kidney injury survivors on patient-centered outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Clinician people
- Hospital clinicians including physicians and advanced practice providers employed by Mayo Clinic and practicing at one of the four study sites
- Provide care for hospitalized patients with stage 2 or stage 3 acute kidney injury (AKI) who are expected to be discharged home and are not receiving...
- Patient people:
- Adults ≥18 years old
You likely can't join if
- Clinician people: Physicians and advanced practice providers who:
- Care exclusively for pediatric patients (\<18 years)
- Care exclusively for patients on palliative care
- Patient people
- Discharged to hospice care
- Require outpatient dialysis at discharge
See the full eligibility criteria
- Clinician people
- Hospital clinicians including physicians and advanced practice providers employed by Mayo Clinic and practicing at one of the four study sites
- Provide care for hospitalized patients with stage 2 or stage 3 acute kidney injury (AKI) who are expected to be discharged home and are not receiving dialysis
- Patient people:
- Adults ≥18 years old
- Meet KDIGO consensus criteria for stage 2 (moderate) or 3 (severe) AKI
- Residence within the study catchment area (southern Minnesota, northern Iowa, or western Wisconsin)
- Clinician people: Physicians and advanced practice providers who:
- Care exclusively for pediatric patients (\<18 years)
- Care exclusively for patients on palliative care
- Patient people
- Discharged to hospice care
- Require outpatient dialysis at discharge
- Are admitted from or expected to be discharged to a skilled nursing facility
- Dementia Diagnosis
- Have undergone solid organ transplant within the past 100 days
- Decline authorization for use of their medical records for research
The study team makes the final eligibility decision.
Where it's taking place
- Mankato, Minnesota, United States
- Rochester, Minnesota, United States
- Eau Claire, Wisconsin, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mankato, Minnesota, United States; Rochester, Minnesota, United States; Eau Claire, Wisconsin, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.